verruca vulgaris

JDD Issue Highlights | June 2022: Acne & Rosacea
acne
by NEXT STEPS IN DERM TEAM on
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …
Intralesional Bleomycin Combined With Cryotherapy in the Treatment of Recalcitrant Verruca Vulgaris
Bleomycin
by NEXT STEPS IN DERM TEAM on
Verruca vulgaris is a common cutaneous manifestation of Human Papillomavirus (HPV) infection that presents as hyperkeratotic, cauliflower-like papules with central black petechiae. These lesions may be resistant to conventional therapies, posing a therapeutic challenge and prolong significant morbidity for the patient. This case report demonstrates an immediate and robust response of recalcitrant …
Imiquimod Cream Therapeutic Cheat Sheet
Imiquimod Therapeutic Cheat Sheet
by Jessica Kalen, MD on
In this month’s installment of our Therapeutic Cheat Sheet Series, we will review the topical immunomodulatory agent imiquimod. Originally approved for the treatment of external genital warts, FDA approval has expanded to include use as field therapy for actinic keratoses as well as treatment of superficial basal cell carcinomas. Here’s what you need to know about imiquimod. [caption id=" …